Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-13

Clinical Trial Update: Efficacy of Pilocarpine 1% in Presbyopia [Phase 3]

View source ↗

Summary

Phase 3 trial update on pilocarpine 1% for presbyopia, with mention of presbyopia and pseudophakia as conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pilocarpine 1% (pilocarpine)

Snippet

Sponsor: Isfahan University of Medical Sciences | Conditions: Presbyopia, Pseudophakia | Phase 3 | Status: UNKNOWN